93 studies found for:    Open Studies | "Prostatic Hyperplasia"
Show Display Options
Rank Status Study
21 Recruiting Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: Prostatic artery embolization;   Procedure: monopolar transurethral prostatectomy
22 Recruiting A Placebo Controlled Study of MR901 for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: talaporfin sodium;   Drug: Saline;   Device: Drug Activator 100 J/cm;   Device: Drug Activator 200 J/cm
23 Recruiting Clinical Trial of Safety and Efficiency of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Afalaza;   Drug: Placebo
24 Recruiting Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Device: Greenlight XPS Laser;   Device: BiVAP Saline Vaporization of the prostate
25 Recruiting Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Conditions: Benign Prostatic Hyperplasia;   BPH;   Lower Urinary Tract Symptoms (LUTS);   LUTS;   Enlarged Prostate
Intervention: Drug: NX-1207
26 Recruiting Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH)
Conditions: Benign Prostatic Hyperplasia;   Lower Urinary Track Symptoms
Interventions: Drug: onaBoNT-A + placebo;   Drug: Tamsulosin + placebo
27 Recruiting Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
28 Recruiting Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostate Hyperplasia
Intervention: Device: Prolieve
29 Not yet recruiting Functional Changes of Urogenital System After Holmium Laser Prostatectomy
Condition: Prostatic Hyperplasia
Intervention:
30 Recruiting Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
Conditions: Benign Prostatic Hypertrophy With Outflow Obstruction;   Overactive Detrusor
Interventions: Procedure: Holmium Laser Enucleation of the Prostate (HoLEP);   Device: Holmium laser enucleation system and morcellator
31 Not yet recruiting Safety and Efficacy of OCL 503 in Prostate Artery Embolization
Conditions: Benign Prostatic Hyperplasia;   Benign Prostatic Hypertrophy
Intervention: Device: Prostate artery embolization.
32 Recruiting A Study of Tadalafil (LY450190) in Participants With Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tadalafil;   Drug: Placebo;   Drug: Alpha1 Blocker
33 Unknown  Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Tamsulosin 0.4mg;   Drug: Tamsulosin 0.2mg
34 Recruiting TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST
Conditions: Prostatic Hyperplasia;   Lower Urinary Tract Symptoms;   Hypogonadism
Interventions: Drug: Testosterone gel 2%;   Other: Placebo
35 Recruiting Laser Prostatectomy Database and Registry
Conditions: Benign Prostatic Hyperplasia;   Enlarged Prostate
Intervention: Other: Registry and Database
36 Recruiting Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System
Condition: Benign Prostatic Hyperplasia
Intervention:
37 Recruiting PERmixon® in LUTS Evaluation Study (PERLES)
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Drug: Permixon® 160 mg;   Drug: Tamsulosine LP;   Drug: Placebo matching Permixon® 160 mg;   Drug: Placebo matching Tamsulosine LP
38 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.
Conditions: Transurethral Resection of Prostate;   Artery Embolization;   Benign Prostatic Hyperplasia;   Lower Urinary Tract Symptoms
Interventions: Procedure: Transarterial Supraselective Embolization of the prostate;   Procedure: Transurethral Resection of the prostate
39 Recruiting KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate)
Condition: BPH (Benign Prostatic Hyperplasia)
Interventions: Device: Green light Laser;   Device: Transurethral Resection of the Prostate (TURP)
40 Recruiting KTP Green Light Prostatectomy Compared With Open Prostatectomy
Condition: BPH (Benign Prostatic Hyperplasia)
Interventions: Procedure: KTP Green Light Prostatectomy;   Device: Green Light;   Procedure: Open prostatectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years